73 related articles for article (PubMed ID: 27221708)
1. Forget about thrombosis: Platelets and Alzheimer's disease, yet another sticky situation.
McFadyen J; Peter K
Sci Signal; 2016 May; 9(429):fs9. PubMed ID: 27221708
[TBL] [Abstract][Full Text] [Related]
2. Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release.
Donner L; Fälker K; Gremer L; Klinker S; Pagani G; Ljungberg LU; Lothmann K; Rizzi F; Schaller M; Gohlke H; Willbold D; Grenegard M; Elvers M
Sci Signal; 2016 May; 9(429):ra52. PubMed ID: 27221710
[TBL] [Abstract][Full Text] [Related]
3. Relevance of N-terminal residues for amyloid-β binding to platelet integrin α
Donner L; Gremer L; Ziehm T; Gertzen CGW; Gohlke H; Willbold D; Elvers M
Cell Signal; 2018 Oct; 50():121-130. PubMed ID: 29964150
[TBL] [Abstract][Full Text] [Related]
4. Increased platelet adhesion and thrombus formation in a mouse model of Alzheimer's disease.
Canobbio I; Visconte C; Oliviero B; Guidetti G; Zarà M; Pula G; Torti M
Cell Signal; 2016 Dec; 28(12):1863-1871. PubMed ID: 27593518
[TBL] [Abstract][Full Text] [Related]
5. Role of heterotrimeric G proteins in platelet activation and clot formation in platelets treated with integrin αIIbβ3 inhibitor.
Budnik I; Shenkman B; Hauschner H; Zilinsky I; Savion N
Platelets; 2018 May; 29(3):265-269. PubMed ID: 28406726
[TBL] [Abstract][Full Text] [Related]
6. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
7. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
8. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K
Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of signaling from receptors of soluble platelet agonists and outside-in signaling in formation of a stable fibrinogen-integrin αIIbβ3-actin cytoskeleton complex.
Budnik I; Shenkman B; Savion N
Thromb Res; 2015 Jan; 135(1):114-20. PubMed ID: 25456731
[TBL] [Abstract][Full Text] [Related]
10. Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression of GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation.
Frojmovic MM; Wong T; Searcy GP
Thromb Haemost; 1996 Dec; 76(6):1047-52. PubMed ID: 8972030
[TBL] [Abstract][Full Text] [Related]
11. Influence of aflibercept on platelet activation profile.
Sobolewska B; Golenko J; Poeschel S; Grimmel C; Gatsiou A; Sopova K; Biedermann T; Schenke-Layland K; Stellos K; Ziemssen F
Exp Eye Res; 2018 Oct; 175():166-172. PubMed ID: 29908884
[TBL] [Abstract][Full Text] [Related]
12. Loss of Reelin protects mice against arterial thrombosis by impairing integrin activation and thrombus formation under high shear conditions.
Gowert NS; Krüger I; Klier M; Donner L; Kipkeew F; Gliem M; Bradshaw NJ; Lutz D; Köber S; Langer H; Jander S; Jurk K; Frotscher M; Korth C; Bock HH; Elvers M
Cell Signal; 2017 Dec; 40():210-221. PubMed ID: 28943410
[TBL] [Abstract][Full Text] [Related]
13. Role of platelets in atherothrombosis.
Jennings LK
Am J Cardiol; 2009 Feb; 103(3 Suppl):4A-10A. PubMed ID: 19166707
[TBL] [Abstract][Full Text] [Related]
14. Activation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stress.
Chen Z; Mondal NK; Ding J; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
Mol Cell Biochem; 2015 Nov; 409(1-2):93-101. PubMed ID: 26160282
[TBL] [Abstract][Full Text] [Related]
15. Cyclophilin A is an important mediator of platelet function by regulating integrin αIIbβ3 bidirectional signalling.
Wang L; Soe NN; Sowden M; Xu Y; Modjeski K; Baskaran P; Kim Y; Smolock EM; Morrell CN; Berk BC
Thromb Haemost; 2014 May; 111(5):873-82. PubMed ID: 24429998
[TBL] [Abstract][Full Text] [Related]
16. Amyloid β-peptide-dependent activation of human platelets: essential role for Ca2+ and ADP in aggregation and thrombus formation.
Canobbio I; Guidetti GF; Oliviero B; Manganaro D; Vara D; Torti M; Pula G
Biochem J; 2014 Sep; 462(3):513-23. PubMed ID: 24984073
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives.
Kalantzi KI; Tsoumani ME; Goudevenos IA; Tselepis AD
Expert Rev Clin Pharmacol; 2012 May; 5(3):319-36. PubMed ID: 22697594
[TBL] [Abstract][Full Text] [Related]
18. Roles of Mac-1 and glycoprotein IIb/IIIa integrins in leukocyte-platelet aggregate formation: stabilization by Mac-1 and inhibition by GpIIb/IIIa blockers.
Patko Z; Csaszar A; Acsady G; Peter K; Schwarz M
Platelets; 2012; 23(5):368-75. PubMed ID: 22671289
[TBL] [Abstract][Full Text] [Related]
19. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
20. GPIIb/IIIa inhibitors: from bench to bedside and back to bench again.
Armstrong PC; Peter K
Thromb Haemost; 2012 May; 107(5):808-14. PubMed ID: 22370973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
